An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Clinical trial NCT02925494 · COMPLETED
Trial details
- NCT number
- NCT02925494
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-14
- Primary completion
- 2018-05-07
- Enrollment
- 433
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.